Search by Drug Name or NDC
NDC 42291-0070-30 Atomoxetine 100 mg/1 Details
Atomoxetine 100 mg/1
Atomoxetine is a ORAL CAPSULE in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by AvKARE. The primary component is ATOMOXETINE HYDROCHLORIDE.
MedlinePlus Drug Summary
Atomoxetine is used as part of a total treatment program to increase the ability to pay attention and decrease impulsiveness and hyperactivity in children and adults with ADHD. Atomoxetine is in a class of medications called selective norepinephrine reuptake inhibitors. It works by increasing the levels of norepinephrine, a natural substance in the brain that is needed to control behavior.
Related Packages: 42291-0070-30Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Atomoxetine
Product Information
NDC | 42291-0070 |
---|---|
Product ID | 42291-070_0e8b3994-a060-af6e-e063-6294a90a60ad |
Associated GPIs | 61354015100180 |
GCN Sequence Number | 060391 |
GCN Sequence Number Description | atomoxetine HCl CAPSULE 100 MG ORAL |
HIC3 | H7Y |
HIC3 Description | TX FOR ATTENTION DEFICIT-HYPERACT.(ADHD), NRI-TYPE |
GCN | 26539 |
HICL Sequence Number | 024703 |
HICL Sequence Number Description | ATOMOXETINE HCL |
Brand/Generic | Generic |
Proprietary Name | Atomoxetine |
Proprietary Name Suffix | n/a |
Non-Proprietary Name | Atomoxetine |
Product Type | HUMAN PRESCRIPTION DRUG |
Dosage Form | CAPSULE |
Route | ORAL |
Active Ingredient Strength | 100 |
Active Ingredient Units | mg/1 |
Substance Name | ATOMOXETINE HYDROCHLORIDE |
Labeler Name | AvKARE |
Pharmaceutical Class | Norepinephrine Reuptake Inhibitor [EPC], Norepinephrine Uptake Inhibitors [MoA] |
DEA Schedule | n/a |
Marketing Category | ANDA |
Application Number | ANDA079022 |
Listing Certified Through | 2025-12-31 |
Package
NDC 42291-0070-30 (42291007030)
NDC Package Code | 42291-070-30 |
---|---|
Billing NDC | 42291007030 |
Package | 30 CAPSULE in 1 BOTTLE (42291-070-30) |
Marketing Start Date | 2022-04-12 |
NDC Exclude Flag | N |
Pricing Information | N/A |